381 related articles for article (PubMed ID: 33386490)
1. Metformin ameliorates the status epilepticus- induced hippocampal pathology through possible mTOR modulation.
Bojja SL; Medhi B; Anand S; Bhatia A; Joshi R; Minz RW
Inflammopharmacology; 2021 Feb; 29(1):137-151. PubMed ID: 33386490
[TBL] [Abstract][Full Text] [Related]
2. Annexin A1-derived peptide Ac
Gimenes AD; Andrade BFD; Pinotti JVP; Oliani SM; Galvis-Alonso OY; Gil CD
J Neuroinflammation; 2019 Feb; 16(1):32. PubMed ID: 30755225
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus.
Trandafir CC; Pouliot WA; Dudek FE; Ekstrand JJ
Neuroscience; 2015 Jan; 284():601-610. PubMed ID: 25453777
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhizin ameliorates oxidative stress and inflammation in hippocampus and olfactory bulb in lithium/pilocarpine-induced status epilepticus in rats.
González-Reyes S; Santillán-Cigales JJ; Jiménez-Osorio AS; Pedraza-Chaverri J; Guevara-Guzmán R
Epilepsy Res; 2016 Oct; 126():126-33. PubMed ID: 27490898
[TBL] [Abstract][Full Text] [Related]
5. Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain.
Hester MS; Hosford BE; Santos VR; Singh SP; Rolle IJ; LaSarge CL; Liska JP; Garcia-Cairasco N; Danzer SC
Exp Neurol; 2016 Jun; 280():1-12. PubMed ID: 26995324
[TBL] [Abstract][Full Text] [Related]
6. Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy.
Drion CM; van Scheppingen J; Arena A; Geijtenbeek KW; Kooijman L; van Vliet EA; Aronica E; Gorter JA
J Neuroinflammation; 2018 Jul; 15(1):212. PubMed ID: 30037344
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus.
Li YJ; Wang L; Zhang B; Gao F; Yang CM
J Pharm Pharmacol; 2019 Mar; 71(3):390-399. PubMed ID: 30417405
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage.
Brewster AL; Lugo JN; Patil VV; Lee WL; Qian Y; Vanegas F; Anderson AE
PLoS One; 2013; 8(3):e57808. PubMed ID: 23536771
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
Langer M; Brandt C; Zellinger C; Löscher W
Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus.
Huang C; Chi XS; Li R; Hu X; Xu HX; Li JM; Zhou D
J Mol Neurosci; 2017 Oct; 63(2):173-184. PubMed ID: 28856625
[TBL] [Abstract][Full Text] [Related]
11. mTOR pathway inhibition prevents neuroinflammation and neuronal death in a mouse model of cerebral palsy.
Srivastava IN; Shperdheja J; Baybis M; Ferguson T; Crino PB
Neurobiol Dis; 2016 Jan; 85():144-154. PubMed ID: 26459113
[TBL] [Abstract][Full Text] [Related]
12. Ketogenic diet exhibits neuroprotective effects in hippocampus but fails to prevent epileptogenesis in the lithium-pilocarpine model of mesial temporal lobe epilepsy in adult rats.
Linard B; Ferrandon A; Koning E; Nehlig A; Raffo E
Epilepsia; 2010 Sep; 51(9):1829-36. PubMed ID: 20633040
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of pentylenetrazole-induced acute status epilepticus in rats by adenosine involves inhibition of the mammalian target of rapamycin pathway.
Wang Y; Liu X; Wang Y; Chen J; Han T; Su L; Zang K
Neuroreport; 2017 Oct; 28(15):1016-1021. PubMed ID: 28902712
[TBL] [Abstract][Full Text] [Related]
14. Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation.
Pérez-Revuelta BI; Hettich MM; Ciociaro A; Rotermund C; Kahle PJ; Krauss S; Di Monte DA
Cell Death Dis; 2014 May; 5(5):e1209. PubMed ID: 24810045
[TBL] [Abstract][Full Text] [Related]
15. LncRNA TUG1 inhibits neuronal apoptosis in status epilepticus rats via targeting the miR-421/mTOR axis.
Yang B; Liang RS; Wu XY; Lin YJ
Cell Signal; 2020 Dec; 76():109787. PubMed ID: 33007387
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-γ agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus.
San YZ; Liu Y; Zhang Y; Shi PP; Zhu YL
Mol Med Rep; 2015 Aug; 12(2):1877-83. PubMed ID: 25891824
[TBL] [Abstract][Full Text] [Related]
17. Targeting of microRNA-21-5p protects against seizure damage in a kainic acid-induced status epilepticus model via PTEN-mTOR.
Tang C; Gu Y; Wang H; Wu H; Wang Y; Meng Y; Han Z; Gu Y; Ma W; Jiang Z; Song Y; Na M; Lu D; Lin Z
Epilepsy Res; 2018 Aug; 144():34-42. PubMed ID: 29751355
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.
van Vliet EA; Forte G; Holtman L; den Burger JC; Sinjewel A; de Vries HE; Aronica E; Gorter JA
Epilepsia; 2012 Jul; 53(7):1254-63. PubMed ID: 22612226
[TBL] [Abstract][Full Text] [Related]
19. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.
Zeng LH; Rensing NR; Wong M
J Neurosci; 2009 May; 29(21):6964-72. PubMed ID: 19474323
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy.
Brandt C; Potschka H; Löscher W; Ebert U
Neuroscience; 2003; 118(3):727-40. PubMed ID: 12710980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]